Loss of CYFIP1 expression has been found in a number of human cancers, including breast cancer, colon cancer, lung cancer, bladder cancer, cutaneous squamous cell carcinoma, nasopharyngeal carcinoma, and acute lymphoblastic leukemia [38, 39, 40, 41]. Here, CYFIP1 is linked to urinary bladder carcinoma.